Deepak Voora
Associate Professor of Medicine with Tenure · Duke University Hospital
Credentials: · ·
History
Research
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
Clinical Pharmacology & Therapeutics · 2008 · 616 citations
The SLCO1B1*5 genetic variant is associated with statin-induced side effects
Journal of the American College of Cardiology · 2009 · First of 7 authors · 359 citations
Clinical Pharmacology & Therapeutics · 2014 · 301 citations
15 papers
12 papers
- JB
9 papers
- JJ
9 papers
9 papers
9 papers
9 papers
- HM
8 papers
Grants
- 2024–2030
National Human Genome Research Institute · U01
PI · $1.2M · Boston Va Research Institute, Inc.
- 2024–2029
Department of Veterans Affairs · I01
Contact PI · Durham Va Medical Center
- 2018–2025
National Human Genome Research Institute · U01
Contact PI · $364.4K · Duke University
- 2013–2019
Development Of Prognostic Platelet RNA Biomarkers To Tailor Antiplatelet Therapy
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.9M · Duke University
Clinical trials
- 2025–2028
Pharmacogenomic Informed Statin Prescribing
Principal investigator · Recruiting
VA Office of Research and Development
- 2013–2016
GM03 - Platelet RNA Signatures of Aspirin
Principal investigator · Completed · Early phase 1
Duke University
- 2013–2016
- 2011–2014
Statin Therapy to Improve Medication Adherence
Principal investigator · Completed · Phase 1
Duke University